Clinical trials
Phase 1 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,340 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 12 |
| 2002 | 11 |
| 2003 | 19 |
| 2004 | 26 |
| 2005 | 32 |
| 2006 | 55 |
| 2007 | 67 |
| 2008 | 66 |
| 2009 | 106 |
| 2010 | 108 |
| 2011 | 132 |
| 2012 | 134 |
| 2013 | 121 |
| 2014 | 125 |
| 2015 | 122 |
| 2016 | 118 |
| 2017 | 152 |
| 2018 | 122 |
| 2019 | 124 |
| 2020 | 115 |
| 2021 | 102 |
| 2022 | 111 |
| 2023 | 85 |
| 2024 | 109 |
| 2025 | 80 |
| 2026 | 58 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,837 |
| Terminated | 225 |
| Recruiting | 115 |
| Active, not recruiting | 92 |
| Unknown status | 39 |
| Withdrawn | 18 |
| Not yet recruiting | 7 |
| Suspended | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 343 |
| Novo Nordisk A/S | 196 |
| Bayer | 145 |
| Novartis Pharmaceuticals | 127 |
| AstraZeneca | 81 |
| GlaxoSmithKline | 69 |
| Eli Lilly and Company | 68 |
| Janssen Research & Development, LLC | 47 |
| Amgen | 36 |
| Hoffmann-La Roche | 36 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 136 |
| Diabetes Mellitus | 124 |
| Diabetes Mellitus, Type 1 | 100 |
| Neoplasms | 92 |
| Carcinoma, Non-Small-Cell Lung | 64 |
| Renal Insufficiency | 54 |
| Colorectal Neoplasms | 50 |
| Leukemia, Myeloid, Acute | 45 |
| Obesity | 42 |
| Asthma | 41 |
Trials
Showing 1 to 25 of 2,340. Each trial links to its page on Pharma Observatory.
2,240 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.